Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria

Journal of Nanobiotechnology

Volumn 13, Issue 1, 2015, Pages

  Cavassin, Emerson Danguy ^a   de Figueiredo, Luiz Francisco Poli ^a   Otoch, José Pinhata ^a   Seckler, Marcelo Martins ^a   de Oliveira, Roberto Angelo ^a   Franco, Fabiane Fantinelli ^a   Marangoni, Valeria Spolon ^a   Zucolotto, Valtencir ^a   Levin, Anna Sara Shafferman ^a   Costa, Silvia Figueiredo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimicrobial test; Multidrug resistant bacteria; Silver nanoparticle

Indexed keywords

ALGAE; BACTERIA; BACTERICIDES; CHITIN; CHITOSAN; DIFFUSION; METAL NANOPARTICLES; MICROBIOLOGY; MICROORGANISMS; NANOPARTICLES; POLYSACCHARIDES; X RAY DIFFRACTION;

ANTI-MICROBIAL TESTS; GRAM-NEGATIVE BACTERIA; MINIMUM BACTERICIDAL CONCENTRATIONS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANTS; RESISTANT STAPHYLOCOCCUS AUREUS; SILVER NANOPARTICLES; VANCOMYCIN-RESISTANT ENTEROCOCCI;

SILVER;

CHITOSAN; CITRIC ACID; SILVER NANOPARTICLE; SILVER NITRATE; SULFADIAZINE SILVER; ANTIINFECTIVE AGENT; METAL NANOPARTICLE; SILVER;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM; BACTERIUM ISOLATION; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT BACTERIA; NONHUMAN; OXACILIN RESISTANT STAPHYLOCOCCUS AUREUS; POLYMYXIN B RESISTANT ACINETOBACTER BAUMANNII; VANCOMYCIN RESISTANT ENTEROCOCCUS; X RAY DIFFRACTION; BACTERIAL INFECTIONS; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; SILVER;

EID: 84943169915     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-015-0120-6     Document Type: Article

References (52)

1. Planquette B, Timsit JF, Misset BY, Schwebel C, Azoulay E, Adrie C, Vesin A, Jamali S, Zahar JR, Allaouchiche B, et al. Pseudomonas aeruginosa ventilator-associated pneumonia predictive factors of treatment failure. Am J Respir Crit Care Med. 2013;188:69-76.
2. Webb GF, D'Agata EMC, Magal P, Ruan S. A model of anti biotic-resistant bacterial epidemics in hospitals. Proc Natl Acad Sci USA. 2005;102:13343-8.
3. Lara HH, Ayala-Nunez NV, Turrent LDI, Padilla CR. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J Microbiol Biotechnol. 2010;26:615-21.
4. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346-53.
5. Ansari MA, Khan HM, Khan AA, Malik A, Sultan A, Shahid M, Shujatullah F, Azam A. Evaluation of antibacterial activity of silver nanoparticles against MSSA and MRSA on isolates from skin infections. Biol Med. 2011;3:141-6.
6. 4@Ag nanoparticles. Nanotechnology. 2007;18:604-11.
7. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010;28:580-8.
8. ISO/TS16550:2014: Nanotechnologies-determination of silver nanoparticles potency by release of muramic acid from Staphylococcus aureus.
9. ISO/TR16197:2014: Nanotechnologies-compilation and description of toxicological screening methods for manufactured nanomaterials.
10. Mirzajani F, Ghassempour A, Aliahmadi A, Esmaeili MA. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Res Microbiol. 2011;162:542-9.
11. Singh K, Panghal M, Kadyan S, Chaudhary U, Yadav JP. Green silver nanoparticles of Phyllanthus amarus: as an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa. J Nanobiotechnol. 2014;12:40.
12. Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B-Biointerf. 2010;79:340-4.
13. Pirnay JP, De Vos D, Cochez C, Bilocq F, Pirson J, Struelens M, Duinslaeger L, Cornelis P, Zizi M, Vanderkelen A. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol. 2003;41:1192-202.
14. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition. CLSI document M07-A9 (ISBN 1-56238-783-9 [Print]; ISBN 1-56238-784-7 [Electronic]). In Clinical and Laboratory Standards Institute. 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA: Clinical and Laboratory Standards Institute; 2012.
15. Pileni MP. Nanosized particles made in colloidal assemblies. Langmuir. 1997;13:3266-76.
16. Solomon SD, Bahadory M, Jeyarajasingam AV, Rutkowsky SA, Boritz C, Mulfinger L. Synthesis and study of silver nanoparticles. J Chem Educ. 2007;84:322-5.
17. Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci. 2009;145:83-96.
18. Coronado EA, Encina ER, Stefani FD. Optical properties of metallic nanoparticles: manipulating light, heat and forces at the nanoscale. Nanoscale. 2011;3:4042-59.
19. Ruparelia JP, Chatteriee AK, Duttagupta SP, Mukherji S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008;4:707-16.
20. Zhang JT, Li XL, Sun XM, Li YD. Surface enhanced Raman scattering effects of silver colloids with different shapes. J Phys Chem B. 2005;109:12544-8.
21. Shameli K, Bin Ahmad M, Yunus W, Rustaiyan A, Ibrahim NA, Zargar M, Abdollahi Y. Green synthesis of silver/montmorillonite/chitosan bionanocomposites using the UV irradiation method and evaluation of antibacterial activity. Int J Nanomed. 2010;5:875-87.
22. Philip D. Biosynthesis of Au, Ag and Au-Ag nanoparticles using edible mushroom extract. Spectrochimica Acta Part a Mol Biomol Spectrosc. 2009;73:374-81.
23. Shankar SS, Ahmad A, Sastry M. Geranium leaf assisted biosynthesis of silver nanoparticles. Biotechnol Prog. 2003;19:1627-31.
24. Wang HS, Qiao XL, Chen JG, Ding SY. Preparation of silver nanoparticles by chemical reduction method. Colloids Surf a-Physicochem Eng Asp. 2005;256:111-5.
25. Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, Thorne PS. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Particle Fibre Toxicol 2011; 8.
26. Ayala-Núñez NV, Villegas HL, Turrent LC, Padilla CR. Silver nanoparticles toxicity and bactericidal effect against methicillin-resistant Staphylococcus aureus: nanoscale Does Matter. NanoBiotechnology. 2009;5:2-9.
27. Jena P, Mohanty S, Mallick R, Jacob B, Sonawane A. Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells. Int J Nanomed. 2012;7:1805-18.
28. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 2007; 18.
29. Patil RS, Kokate MR, Jambhale CL, Pawar SM, Han SH, Kolekar SS. One-pot synthesis of PVA-capped silver nanoparticles their characterization and biomedical application. Adv Nat Sci Nanosci Nanotechnol. 2012;3:015013.
30. Nowack B, Krug HF, Height M. 120 years of nanosilver history: implications for policy makers. Environ Sci Technol. 2011;45:1177-83.
31. Schacht VJ, Neumann LV, Sandhi SK, Chen L, Henning T, Klar PJ, Theophel K, Schnell S, Bunge M. Effects of silver nanoparticles on microbial growth dynamics. J Appl Microbiol. 2013;114:25-35.
32. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27:76-83.
33. Zhao GJ, Stevens SE. Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion. Biometals. 1998;11:27-32.
34. Loo CY, Young PM, Lee WH, Cavaliere R, Whitchurch CB, Rohanizadeh R. Non-cytotoxic silver nanoparticle-polyvinyl alcohol hydrogels with anti-biofilm activity: designed as coatings for endotracheal tube materials. Biofouling. 2014;30:773-88.
35. Rai MK, Deshmukh SD, Ingle AP, Gade AK. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol. 2012;112:841-52.
36. Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ. Metal oxide nanoparticles as bactericidal agents. Langmuir. 2002;18:6679-86.
37. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E-coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275:177-82.
38. Benhabiles S, Salah R, Lounici H, Drouiche N, Goosen MFA, Mameri N. Antibacterial activity of chitin, chitosan and its oligomers prepared from shrimp shell waste. Food Hydrocolloids. 2012;29:48-56.
39. Sanpui P, Murugadoss A, Prasad PVD, Ghosh SS, Chattopadhyay A. The antibacterial properties of a novel chitosan-Ag-nanoparticle composite. Int J Food Microbiol. 2008;124:142-6.
40. Dawy M, Rifaat HM, Moustafa SA, Mousa HA. Physicochemical studies on nano silver particles preparated by different techniques. Aust J Basic Appl Sci. 2012;6:257-62.
41. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PKH, Chiu JF, Che CM. Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem. 2007;12:527-34.
42. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med. 2007;3:95-101.
43. Egger S, Lehmann RP, Height MJ, Loessner MJ, Schuppler M. Antimicrobial properties of a novel silver-silica nanocomposite material. Appl Environ Microbiol. 2009;75:2973-6.
44. Singh K, Panghal M, Kadyan S, Chaudhary U, Yadav JP. Antibacterial activity of synthesized silver nanoparticles from Tinospora cordifolia against multi drug resistant strains of Pseudomonas aeruginosa isolated from burn patients. J Nanomed Nanotechnol. 2014;5:192.
45. Khanna PK, Singh N, Charan S, Subbarao V, Gokhale R, Mulik UP. Synthesis and characterization of Ag/PVA nanocomposite by chemical reduction method. Mater Chem Phys. 2005;93:117-21.
46. Lee PC, Meisel D. Adsorption and surface-enhanced Raman of dyes on silver and gold sols. J Phys Chem. 1982;86:3391-5.
47. Temgire MK, Joshi SS. Optical and structural studies of silver nanoparticles. Radiat Phys Chem. 2004;71:1039-44.
48. Cao XL, Cheng C, Ma YL, Zhao CS. Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities. J Mat Sci Mat Med. 2010;21:2861-8.
49. Shih CM, Shieh YT, Twu YK. Preparation of gold nanopowders and nanoparticles using chitosan suspensions. Carbohydr Polym. 2009;78:309-15.
50. Hindler J. Tests to assess bactericidal activity. In: Isenberg HD, editor. Clinical microbiology procedures handbook. Washington, D.C.: American Society for Microbiology; 1992.
51. Leite AM, Lima EO, Souza EL, Diniz MF, TrajanoII VN, Medeiros IA. Inhibitory effect of b-pinene, a-pinene and eugenol on the growth of potential infectious endocarditis causing Gram-positive bacteria. Revista Brasileira de Ciências Farmacêuticas. 2007;43:121-6.
52. GiamarellosBouroulis EJ, Grecka P, Giamarellou H. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 1997;29:81-6.